Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · IEX Real-Time Price · USD
15.50
+0.27 (1.77%)
At close: May 1, 2024, 4:00 PM
16.22
+0.72 (4.65%)
After-hours: May 1, 2024, 7:45 PM EDT
Arcus Biosciences Employees
Arcus Biosciences had 577 employees on December 31, 2023. The number of employees increased by 77 or 15.40% compared to the previous year.
Employees
577
Change (1Y)
77
Growth (1Y)
15.40%
Revenue / Employee
$202,773
Profits / Employee
-$532,062
Market Cap
1.41B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 577 | 77 | 15.40% |
Dec 31, 2022 | 500 | 134 | 36.61% |
Dec 31, 2021 | 366 | 130 | 55.08% |
Dec 31, 2020 | 236 | 97 | 69.78% |
Dec 31, 2019 | 139 | 31 | 28.70% |
Dec 31, 2018 | 108 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Warby Parker | 3,491 |
ANI Pharmaceuticals | 642 |
LeMaitre Vascular | 630 |
InMode | 581 |
Neumora Therapeutics | 124 |
Morphic Holding | 121 |
Akero Therapeutics | 56 |
RCUS News
- 7 days ago - Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting - Business Wire
- 8 days ago - Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update - Business Wire
- 22 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 2 months ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 2 months ago - Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update - Business Wire
- 3 months ago - Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates - Business Wire
- 3 months ago - Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% - Reuters
- 3 months ago - Gilead and Arcus Announce Amended Collaboration and Equity Investment - Business Wire